DeutschNewstral
Article
Fft.com on 2018-06-12 18:58
AstraZeneca and Eli Lilly scrap Alzheimer’s trial
Related news
Eli Lilly, AstraZeneca Drop Two Late-Stage Alzheimer’s Drug Trialswsj.com- FRoche and Eli Lilly drugs fail ‘inherited’ Alzheimer’s trialft.com
Eli Lilly & Co: Eli Lilly to seek US approval after Alzheimer’s drug trial successFinancial Times- MEli Lilly CEO on slicing tips, potential weight problems drug, Alzheimer’s trialmvtelegraph.com
- FEli Lilly raises Alzheimer’s drug hopesft.com
- FEli Lilly chief seeks to recover from Alzheimer’s drug flopft.com
- Dementia: Eli Lilly drug shown to slow Alzheimer’s progressionFinancial Times
- Eli Lilly Changes Goal of Alzheimer’s Trialwsj.com
- FEli Lilly & Co: US regulator delays decision on Eli Lilly’s Alzheimer’s drugft.com
- MEli Lilly and AstraZeneca to co-develop Alzheimer's Disease treatmentmarketwatch.com
- Eli Lilly & Co: Eli Lilly weight-loss drug found to address sleep apnoea in trialFinancial Times
- DEli Lilly slumps after disappointing Zepbound weight-loss-drug trialdcourier.com
Eli Lilly pauses coronavirus drug trial for safety reasonsisraelnationalnews.com
Eli Lilly antibody trial paused over safety concernsPOLITICO- Lilly Alzheimer’s Drug Shows Modest Benefit in Trialwsj.com
- GAlzheimer’s Disease Diagnostic Market Impact and Recovery Analysis| Eli Lilly, TauRx, Alectorgalleonnews.com
- MEli Lilly recruits black sufferers for Alzheimer’s examine, drugmakers try for rangemvtelegraph.com
- IEli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’invezz.com
- Eli Lilly achieves hard-won success with Alzheimer’s and obesity drugsFinancial Times
- FPharmaceuticals: Alzheimer’s drug failure deals blow to US drugmaker Eli Lillyft.com